AJG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AJG is a good buy for a beginner with a long-term focus and $50,000-$100,000 to invest. The stock is not showing a strong immediate technical breakout, but the business fundamentals, analyst sentiment, congress buying, and sector support are constructive enough to justify buying now rather than waiting for a perfect entry. For a patient long-term investor, this is a solid accumulation candidate.
AJG is in a short-term weak trend technically: MACD histogram is negative at -1.913, RSI_6 is 32.701, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price at 202 is just above S1 support at 197.625 and below the pivot at 207.072, suggesting the stock is near support rather than in a confirmed uptrend. The near-term pattern data still implies a positive bias, with estimated upside of 2.76% over the next week and 4.62% over the next month, but technically this is more of a buy-on-weakness setup than a momentum buy.
Recent catalysts are strong: Citi upgraded AJG to Buy and said the stock has at least 15% upside as insurance sector conditions improve. AJG also reported Q1 2026 revenue growth of 27.65% YoY, net income growth of 16.70% YoY, and EPS growth of 16.18% YoY. Management maintained 2026 guidance and expects 6% organic growth plus $160 million in annualized run-rate synergies. The company completed 9 mergers in Q1, which should add about $60 million in annualized revenue. Congress trading also looks positive, with 3 recent purchase transactions and no sales.
The main negatives are technical and flow-related: hedge funds are selling heavily, with selling up 5037.71% over the last quarter, and insiders are neutral. Analysts are mixed overall, with several firms lowering price targets, including Morgan Stanley, Truist, Keefe Bruyette, and Piper Sandler. The company’s gross margin fell 9.67% YoY, and brokerage-sector commentary still points to sluggish premium and organic growth in the near term. Technicals also remain bearish below key moving averages.
Latest quarter: Q1 2026. Financial results were strong overall. Revenue rose to $4.758 billion, up 27.65% YoY, net income increased to $822 million, up 16.70% YoY, and EPS grew to 3.16, up 16.18% YoY. The main weakness was gross margin, which declined to 40, down 9.67% YoY. For a long-term investor, the growth trend is healthy, and the margin compression appears manageable given the strong M&A-driven expansion and synergy outlook.
Analyst sentiment is mixed but improving. The most recent actions include Citi upgrading AJG to Buy with a $250 target, Morgan Stanley trimming its target to $265 while keeping Overweight, and Mizuho raising its target to $261 with Outperform. However, several firms cut targets and stayed neutral/hold, including Truist, Keefe Bruyette, Piper Sandler, and Barclays noted sluggish growth. Wall Street’s pros: strong scale, capital deployment, M&A execution, and AI productivity upside. Cons: valuation compression, slower organic growth, and margin pressure. Overall, the analyst trend is constructive but not unanimously bullish.
